These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22538356)

  • 1. Neuroprotection and estrogen receptors.
    Simpkins JW; Singh M; Brock C; Etgen AM
    Neuroendocrinology; 2012; 96(2):119-30. PubMed ID: 22538356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-feminizing estrogens: a novel neuroprotective therapy.
    Petrone AB; Gatson JW; Simpkins JW; Reed MN
    Mol Cell Endocrinol; 2014 May; 389(1-2):40-7. PubMed ID: 24424441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
    Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons.
    Zhao L; Wu TW; Brinton RD
    Brain Res; 2004 Jun; 1010(1-2):22-34. PubMed ID: 15126114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection.
    Marin R; Guerra B; Alonso R; Ramírez CM; Díaz M
    Curr Neurovasc Res; 2005 Oct; 2(4):287-301. PubMed ID: 16181121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.
    Liu X; Fan XL; Zhao Y; Luo GR; Li XP; Li R; Le WD
    J Neurosci Res; 2005 Sep; 81(5):653-65. PubMed ID: 16013043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
    Correia SC; Santos RX; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Curr Aging Sci; 2010 Jul; 3(2):113-26. PubMed ID: 20167003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.
    Yang LC; Zhang QG; Zhou CF; Yang F; Zhang YD; Wang RM; Brann DW
    PLoS One; 2010 May; 5(5):e9851. PubMed ID: 20479872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens and neuroprotection in retinal diseases.
    Kumar DM; Simpkins JW; Agarwal N
    Mol Vis; 2008 Aug; 14():1480-6. PubMed ID: 18698377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism of non-feminizing estrogens in neuroprotection.
    Engler-Chiurazzi EB; Covey DF; Simpkins JW
    Exp Gerontol; 2017 Aug; 94():99-102. PubMed ID: 27818250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells--implications for neuroprotection against Ca-mediated excitotoxicity.
    Gamerdinger M; Manthey D; Behl C
    J Neurochem; 2006 Apr; 97(1):57-68. PubMed ID: 16524385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons.
    Cordey M; Pike CJ
    Brain Res; 2005 May; 1045(1-2):217-23. PubMed ID: 15910780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by ovarian hormones in animal models of neurological disease.
    Hoffman GE; Merchenthaler I; Zup SL
    Endocrine; 2006 Apr; 29(2):217-31. PubMed ID: 16785598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation.
    Yi KD; Cai ZY; Covey DF; Simpkins JW
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1188-95. PubMed ID: 18089844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.
    Prokai L; Simpkins JW
    Pharmacol Ther; 2007 Apr; 114(1):1-12. PubMed ID: 17336390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
    Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
    Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen as a neuroprotective hormone.
    Behl C
    Nat Rev Neurosci; 2002 Jun; 3(6):433-42. PubMed ID: 12042878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of non-feminizing estrogens for use in neuroprotection.
    Yi KD; Perez E; Yang S; Liu R; Covey DF; Simpkins JW
    Brain Res; 2011 Mar; 1379():61-70. PubMed ID: 21111714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.